phenytoin has been researched along with oxyphenbutazone in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (81.82) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.55) | 29.6817 |
| 2010's | 3 (13.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Hausmann, K; Sachtleben, P; Skrandies, G | 2 |
| Levy, G; Soda, DM | 1 |
| Jatlow, P | 1 |
| McQueen, EG | 1 |
| Ganshorn, A; Kurz, H | 1 |
| Gladner, JA; Houck, JC; Patel, YM; Sharma, VK | 1 |
| Weinmann, HM; Willms, E | 1 |
| Danckwardt-Lillieström, G; Grevsten, S; Olerud, S | 1 |
| Altland, K; Goedee, HW | 1 |
| Huber, Z; Spalona, M | 1 |
| Asahi, K; Iizuka, H; Okabe, Y; Yanagida, T | 1 |
| Breuer, U; Lempp, R | 1 |
| EYSOLD, R | 1 |
| KIORBOE, E; OVERVAD, E; PALUDAN, J; TROLLE, E | 1 |
| CRAIG, WS; MACKINNON, JM | 1 |
2 review(s) available for phenytoin and oxyphenbutazone
| Article | Year |
|---|---|
Current drug therapy--antiepilepsy agents.
Topics: Anticonvulsants; Barbiturates; Chemical Phenomena; Chemistry; Drug Interactions; Epilepsies, Partial; Epilepsy; Epilepsy, Absence; Epilepsy, Temporal Lobe; Epilepsy, Tonic-Clonic; Humans; Hydantoins; Intestinal Absorption; Microsomes, Liver; Motor Cortex; Myoclonus; Oxyphenbutazone; Phenytoin; Skin Manifestations; Structure-Activity Relationship; Succinimides | 1974 |
[Genetically dependent variability of drug effects].
Topics: Anemia, Hemolytic; Anesthesia, General; Anesthetics; Animals; Antipyrine; Apnea; Atropine; Body Temperature; Coumarins; Cyanosis; Deficiency Diseases; Dexamethasone; Dogs; Drug Tolerance; Enzymes; Female; Glucosephosphate Dehydrogenase; Humans; Intraocular Pressure; Isonicotinic Acids; Male; Meperidine; Mice; Oxyphenbutazone; Pharmacogenetics; Phenacetin; Phenylbutazone; Phenytoin; Proteins; Rabbits; Rats; Succinylcholine | 1970 |
1 trial(s) available for phenytoin and oxyphenbutazone
| Article | Year |
|---|---|
[Short report on the effect of the anticonvulsant Ro 5-4023 (clonazepam) in different forms of epilepsy].
Topics: Adolescent; Anticonvulsants; Barbiturates; Benzodiazepinones; Carbamazepine; Child; Child, Preschool; Chlorobenzenes; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Electroencephalography; Epilepsy; Female; Hormones; Humans; Infant; Male; Nitrazepam; Nitro Compounds; Oxyphenbutazone; Phenytoin; Succinimides; Valerates | 1973 |
19 other study(ies) available for phenytoin and oxyphenbutazone
| Article | Year |
|---|---|
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
IARC monographs on the evaluation of the carcinogenic risk of chemicals to man: some miscellaneous pharmaceutical substances.
Topics: Acriflavine; Animals; Anthralin; Aurothioglucose; Carcinogens; Chloroquine; Diazepam; Ethanolamines; Ethionamide; Female; Humans; Hycanthone; Male; Metronidazole; Neoplasms; Neoplasms, Experimental; Oxazepam; Oxymetholone; Oxyphenbutazone; Oxyquinoline; Phenacetin; Phenobarbital; Phenylbutazone; Phenytoin; Pregnancy; Pyrimethamine; Risk | 1977 |
[Current aspects of iatrogenic lesions of the bone marrow].
Topics: Anemia, Aplastic; Anemia, Macrocytic; Anemia, Megaloblastic; Bone Marrow Diseases; Chloramphenicol; Drug-Related Side Effects and Adverse Reactions; Gold; Humans; Oxyphenbutazone; Phenylbutazone; Phenytoin; Sulfonamides | 1976 |
Inhibition of drug metabolism by hydroxylated metabolites: cross-inhibition and specificity.
Topics: Animals; Antipyrine; Biotransformation; Depression, Chemical; Half-Life; Hydroxylation; Male; Oxidation-Reduction; Oxyphenbutazone; Pharmaceutical Preparations; Phenytoin; Rats; Sulfanilamides; Time Factors | 1975 |
Ultraviolet spectrophotometric analysis of barbiturates: evaluation of potential interferences.
Topics: Acetaminophen; Barbiturates; Chlorothiazide; Chlorpropamide; Dicumarol; Humans; Methods; Nicotinic Acids; Oxyphenbutazone; Phenacetin; Phenindione; Phenobarbital; Phenylbutazone; Phenytoin; Salicylates; Spectrophotometry, Ultraviolet; Sulfamethoxazole; Sulfinpyrazone; Sulfisoxazole; Theobromine; Theophylline; Warfarin | 1973 |
Drug displacement from protein-binding and redistributional interactions.
Topics: Animals; Blood Proteins; Carboxylic Acids; Clofibrate; DDT; Dieldrin; Guanidines; Hexachlorocyclohexane; Humans; Kinetics; Oxyphenbutazone; Pharmaceutical Preparations; Phenylbutazone; Phenytoin; Protein Binding; Rats; Sheep; Ultrafiltration; Warfarin | 1974 |
[Present aspects of bone marrow lesions due to drugs (author's transl)].
Topics: Anemia, Aplastic; Bone Marrow Diseases; Chloramphenicol; Drug-Related Side Effects and Adverse Reactions; Germany, West; Gold; Humans; Oxyphenbutazone; Phenylbutazone; Phenytoin; Sulfonamides; Sweden; United States | 1974 |
[Differences between the protein binding of newborns and adults and their importance for pharmacological action].
Topics: Acetaminophen; Age Factors; Aminosalicylic Acids; Atropine; Chloramphenicol; Humans; Infant, Newborn; Isoniazid; Methicillin; Morphine; Nitrofurantoin; Oxyphenbutazone; Phenacetin; Phenobarbital; Phenytoin; Promethazine; Protein Binding; Salicylates; Sulfadimethoxine; Thiopental | 1968 |
Induction of collagenolytic and proteolytic activities by anti-inflammatory drugs in the skin and fibroblast.
Topics: Animals; Collagen; Culture Techniques; Cycloheximide; Dactinomycin; Depression, Chemical; Enzyme Induction; Fibroblasts; Glucuronidase; Hydrocortisone; Indomethacin; Male; Microbial Collagenase; Oxyphenbutazone; Peptide Hydrolases; Phenytoin; Puromycin; Rats; RNA; Skin; Stimulation, Chemical | 1968 |
Investigation of effect of various agents on periosteal bone formation.
Topics: Animals; Bone Marrow; Bone Regeneration; Casts, Surgical; Enteral Nutrition; Injections, Subcutaneous; Methods; Nandrolone; Oxyphenbutazone; Periosteum; Phenytoin; Placebos; Rabbits; Sodium Chloride; Tibia; Time Factors | 1972 |
[Treatment of epilepsy with a combination of anticonvulsants in a group refractory to previously used drugs].
Topics: Adolescent; Adult; Aged; Anticonvulsants; Barbiturates; Child; Drug Synergism; Drug Tolerance; Epilepsy; Humans; Middle Aged; Oxyphenbutazone; Phenytoin; Pyrimidinones; Time Factors | 1971 |
[Influence of food deprivation on efficacy and toxicity of drugs in mice].
Topics: Acetates; Aminopyrine; Analgesics; Animals; Anticonvulsants; Blood Glucose; Blood Proteins; Body Weight; Carrageenan; Cholesterol; Citrates; Female; Male; Methylcellulose; Mice; Oxyphenbutazone; Pectins; Pentobarbital; Pentylenetetrazole; Pharmacology; Phenytoin; Starvation; Time Factors; Toxicology | 1969 |
[The necessary dosis of antiepileptic drugs in epileptic children during their growth period].
Topics: Adolescent; Adult; Anticonvulsants; Barbiturates; Body Weight; Child; Child Development; Child, Preschool; Epilepsy; Ethosuximide; Female; Growth; Humans; Infant; Male; Oxyphenbutazone; Phenytoin; Primidone | 1968 |
[GENESIS, CLASSIFICATION AND THERAPY OF LOSS OF CONSCIOUSNESS].
Topics: Caffeine; Child; Classification; Electroencephalography; Epilepsy; Epilepsy, Absence; Humans; Oxyphenbutazone; Phenobarbital; Phenytoin; Physiology; Pyrrolidinones; Unconsciousness | 1963 |
ZARONTIN (ETHOSUXIMIDE) IN THE TREATMENT OF PETIT MAL AND RELATED DISORDERS.
Topics: Adolescent; Anticonvulsants; Biomedical Research; Child; Denmark; Drug Therapy; Epilepsy; Epilepsy, Absence; Epilepsy, Tonic-Clonic; Ethosuximide; Humans; Infant; Myoclonus; Oxyphenbutazone; Phenobarbital; Phenytoin; Pyrrolidinones; Seizures; Toxicology | 1964 |
CHILD CARE IN GENERAL PRACTICE. CONVULSIONS IN INFANCY AND CHILDHOOD. II.
Topics: Acetazolamide; Anticonvulsants; Bromides; Child; Child Care; Chloral Hydrate; Diagnosis; Drug Therapy; Electroencephalography; Epilepsy; Ethosuximide; Family Practice; General Practice; Hospitalization; Humans; Infant; Oxyphenbutazone; Paraldehyde; Phenobarbital; Phenytoin; Primidone; Prognosis; Radiography; Seizures; Toxicology | 1965 |